Literature DB >> 15287035

Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.

Chris H J Terhaard1, H Lubsen, I Van der Tweel, F J M Hilgers, W M H Eijkenboom, H A M Marres, R E Tjho-Heslinga, J M A de Jong, J L N Roodenburg.   

Abstract

BACKGROUND: We analyzed the records of patients with malignant salivary gland tumors, as diagnosed in centers of the Dutch Head and Neck Oncology Cooperative Group, in search of independent prognostic factors for locoregional control, distant metastases, and overall survival.
METHODS: In 565 patients, we analyzed general results and looked for the potential prognostic variables of age, sex, delay, clinical and pathologic T and N stage, site (332 parotid, 76 submandibular, 129 oral cavity, 28 pharynx/larynx), pain, facial weakness, clinical and pathologic skin involvement, histologic type (WHO 1972 classification), treatment, resection margins, spill, perineural and vascular invasion, number of neck nodes, and extranodal disease. The median follow-up period was 74 months; it was 99 months for patients who were alive on the last follow-up.
RESULTS: The rates of local control, regional control, distant metastasis-free and overall survival after 10 years were, respectively, 78%, 87%, 67%, and 50%. In multivariable analysis, local control was predicted by clinical T-stage, bone invasion, site, resection margin, and treatment. Regional control depended on N stage, facial nerve paralysis, and treatment. The relative risk with surgery alone, compared to surgery plus postoperative radiotherapy, was 9.7 for local recurrence and 2.3 for regional recurrence. Distant metastases were independently correlated with T and N stage, sex, perineural invasion, histologic type, and clinical skin involvement. Overall survival depended on age, sex, T and pN stage, site, skin and bone invasion.
CONCLUSIONS: Several prognostic factors for locoregional control, distant metastases, and overall survival were found. Postoperative radiotherapy was found to improve locoregional control. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15287035     DOI: 10.1002/hed.10400

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  94 in total

1.  Prioritizing phase I treatment options through preclinical testing on personalized tumorgraft.

Authors:  M Pia Morelli; Emiliano Calvo; Esther Ordoñez; Michael J Wick; Belen-Rubio Viqueira; Pedro P Lopez-Casas; Elizabeth Bruckheimer; Antonio Calles-Blanco; David Sidransky; Manuel Hidalgo
Journal:  J Clin Oncol       Date:  2011-12-19       Impact factor: 44.544

2.  [On the diagnosis and treatment of parotid gland tumors. Results of a nationwide survey of ENT hospitals in Germany].

Authors:  S F Preuss; O Guntinas-Lichius
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

3.  Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy.

Authors:  Trevor M Feinstein; Stephen Y Lai; Diana Lenzner; William Gooding; Robert L Ferris; Jennifer R Grandis; Eugene N Myers; Jonas T Johnson; Dwight E Heron; Athanassios Argiris
Journal:  Head Neck       Date:  2011-01-31       Impact factor: 3.147

4.  Incidence of cervical lymph node metastasis and its association with outcomes in patients with adenoid cystic carcinoma. An international collaborative study.

Authors:  Moran Amit; Yoav Binenbaum; Kanika Sharma; Naomi Ramer; Ilana Ramer; Abib Agbetoba; Joelle Glick; Xinjie Yang; Delin Lei; Kristine Bjørndal; Christian Godballe; Thomas Mücke; Klaus-Dietrich Wolff; Dan Fliss; André M Eckardt; Chiara Copelli; Enrico Sesenna; Frank Palmer; Ian Ganly; Snehal Patel; Ziv Gil
Journal:  Head Neck       Date:  2014-07-24       Impact factor: 3.147

Review 5.  Review of clinical experience with ion beam radiotherapy.

Authors:  A D Jensen; M W Münter; J Debus
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

Review 6.  Salivary mucoepidermoid carcinoma revisited.

Authors:  Andrés Coca-Pelaz; Juan P Rodrigo; Asterios Triantafyllou; Jennifer L Hunt; Alessandra Rinaldo; Primož Strojan; Missak Haigentz; William M Mendenhall; Robert P Takes; Vincent Vander Poorten; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-26       Impact factor: 2.503

7.  Feeding Tube Utilization in Patients with Salivary Gland Malignancies.

Authors:  Diane Wenhua Chen; Jan S Lewin; Li Xu; Stephen Y Lai; G Brandon Gunn; Clifton David Fuller; Abdallah S R Mohamed; Aasheesh Kanwar; Erich M Sturgis; Katherine A Hutcheson
Journal:  Otolaryngol Head Neck Surg       Date:  2016-10-03       Impact factor: 3.497

Review 8.  Salivary gland carcinomas.

Authors:  Tobias Ettl; Stephan Schwarz-Furlan; Martin Gosau; Torsten E Reichert
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

9.  [Adenoid cystic carcinoma of the oropharynx. Brachytherapy for the treatment of local recurrences].

Authors:  H Badakhshi; S Marnitz; H Scherer; V Budach; A Haisch
Journal:  HNO       Date:  2008-03       Impact factor: 1.284

10.  Treatment Results of Major Salivary Gland Cancer by Surgery with or without Postoperative Radiation Therapy.

Authors:  Jae Myoung Noh; Yong Chan Ahn; Heerim Nam; Won Park; Chung-Hwan Baek; Young-Ik Son; Han-Sin Jeong
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-06-30       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.